Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

5 structures for P22234

Entry ID Method Resolution Chain Position Source
2H31 X-ray 280 A A 1-425 PDB
6YB8 X-ray 236 A A/B 1-425 PDB
6YB9 X-ray 241 A A/B 1-425 PDB
7ALE X-ray 295 A A/B 1-425 PDB
AF-P22234-F1 Predicted AlphaFoldDB

316 variants for P22234

Variant ID(s) Position Change Description Diseaes Association Provenance
CA2930671
VAR_085931
rs192831239
53 K>R PAICSD; unknown pathological significance; no effect on protein abundance; decreased phosphoribosylaminoimidazole carboxylase activity; decreased phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [UniProt] Yes ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA2930631
rs774260057
2 A>S No ClinGen
ExAC
TOPMed
gnomAD
CA97607918
rs1044061502
3 T>A No ClinGen
Ensembl
rs906895206
CA97607919
5 E>G No ClinGen
Ensembl
rs1167041596
CA356982567
7 L>P No ClinGen
gnomAD
CA356982568
rs1167041596
7 L>R No ClinGen
gnomAD
CA2930651
rs748878127
8 N>S No ClinGen
ExAC
gnomAD
rs768421711
CA2930652
9 I>V No ClinGen
ExAC
gnomAD
CA2930653
rs773985258
11 K>E No ClinGen
ExAC
gnomAD
rs553472600
CA97611749
13 L>S No ClinGen
1000Genomes
gnomAD
CA356982644
rs1340737667
14 Y>C No ClinGen
gnomAD
rs761645139
CA2930654
14 Y>H No ClinGen
ExAC
gnomAD
rs761645139
CA356982638
14 Y>N No ClinGen
ExAC
gnomAD
rs1431936983
CA356982705
20 E>Q No ClinGen
gnomAD
rs746244172
CA97611757
22 Y>* No ClinGen
ExAC
TOPMed
gnomAD
CA2930656
rs773166026
23 E>K Variant assessed as Somatic; 4.751e-05 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA2930657
rs377520975
24 L>F No ClinGen
ESP
ExAC
gnomAD
CA2930659
rs752884317
26 D>G No ClinGen
ExAC
gnomAD
rs1220331088
CA356982769
26 D>H No ClinGen
gnomAD
CA356982786
rs1488708849
27 S>T No ClinGen
gnomAD
rs1328329910
CA356982797
28 P>A No ClinGen
TOPMed
CA2930660
rs763085698
30 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs1225475816
CA356982836
32 L>F No ClinGen
TOPMed
rs370970867
CA356982846
33 L>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs370970867
CA2930662
33 L>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA356982852
rs1182426731
34 Q>* No ClinGen
gnomAD
CA356982854
rs1384522348
34 Q>P No ClinGen
TOPMed
gnomAD
CA356982855
rs1384522348
34 Q>R No ClinGen
TOPMed
gnomAD
CA2930664
rs775711628
35 S>F No ClinGen
ExAC
TOPMed
gnomAD
rs199691030
CA2930665
36 K>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA356982898
rs1318110187
38 Q>* No ClinGen
gnomAD
rs1343839010
CA356982905
38 Q>H No ClinGen
gnomAD
rs1450601608
CA356982910
39 I>V No ClinGen
gnomAD
rs370569487
CA2930666
40 T>I No ClinGen
ESP
ExAC
gnomAD
CA356982932
rs1412521425
41 A>T No ClinGen
gnomAD
CA97611902
rs199981225
43 N>D No ClinGen
1000Genomes
rs1382688404
CA356982975
44 A>T No ClinGen
gnomAD
CA2930668
rs779424819
47 K>R No ClinGen
ExAC
gnomAD
rs1204821757
CA356983058
48 N>K No ClinGen
gnomAD
rs1459808803
CA356983080
49 H>D No ClinGen
gnomAD
CA2930670
rs768171255
51 E>* No ClinGen
ExAC
gnomAD
TCGA novel 54 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1346239994
CA356983244
55 A>T No ClinGen
TOPMed
CA2930672
rs562121018
56 I>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA356983358
rs773078210
60 I>M No ClinGen
ExAC
TOPMed
gnomAD
rs1156492402
CA356983361
61 T>A No ClinGen
gnomAD
CA2930675
rs760596362
62 S>C No ClinGen
ExAC
TOPMed
gnomAD
rs1337739543
CA356983384
63 C>R No ClinGen
TOPMed
gnomAD
rs1406025616
CA356983445
66 Q>* No ClinGen
gnomAD
CA356983516
rs1333921816
69 Q>P No ClinGen
gnomAD
CA2930677
rs775405273
70 E>K No ClinGen
ExAC
gnomAD
rs1238406116
CA356983575
72 G>S No ClinGen
gnomAD
CA356984980
rs1188680247
73 I>M No ClinGen
gnomAD
CA356984988
rs1165923819
74 K>Q No ClinGen
gnomAD
rs1262815645
CA356985107
78 T>N No ClinGen
gnomAD
rs1488276773
CA356985160
81 C>R No ClinGen
TOPMed
rs1028051898
CA97615565
81 C>Y No ClinGen
Ensembl
CA356985191
rs1387615130
82 G>E No ClinGen
gnomAD
CA97615567
rs955142146
83 E>V No ClinGen
Ensembl
CA356985239
rs1162935974
84 T>I No ClinGen
gnomAD
CA356985263
rs1363956805
85 A>G No ClinGen
TOPMed
gnomAD
TCGA novel 86 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs767891808
CA2930701
89 P>L No ClinGen
ExAC
gnomAD
rs1560660262
CA356985392
92 E>G No ClinGen
Ensembl
CA356985388
rs1384037483
92 E>K No ClinGen
TOPMed
gnomAD
CA356985457
rs1578152271
94 I>T No ClinGen
Ensembl
CA356985467
rs1380298440
95 P>T No ClinGen
gnomAD
CA2930703
rs201315571
96 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs766756958
CA2930704
98 W>L No ClinGen
ExAC
TOPMed
gnomAD
rs754374739
CA2930705
99 V>L No ClinGen
ExAC
TOPMed
gnomAD
rs1312223382
CA356985573
101 R>G No ClinGen
gnomAD
CA2930706
rs754389538
102 R>I No ClinGen
ExAC
gnomAD
CA356985622
rs1216109465
103 I>M No ClinGen
gnomAD
TCGA novel 104 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2930707
rs369183397
105 T>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1485776828
CA356985642
105 T>I No ClinGen
gnomAD
CA356985651
rs1397940239
106 G>D No ClinGen
TOPMed
CA2930708
rs752273829
110 K>R No ClinGen
ExAC
gnomAD
TCGA novel 113 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA356985746
rs1245515166
113 P>T No ClinGen
TOPMed
gnomAD
rs758019237
CA2930709
114 G>S No ClinGen
ExAC
TOPMed
gnomAD
CA2930710
rs777455868
116 K>E No ClinGen
ExAC
TOPMed
gnomAD
rs746737970
CA2930711
117 E>Q No ClinGen
ExAC
gnomAD
rs757076250
CA2930712
118 G>R No ClinGen
ExAC
gnomAD
CA356985824
rs1363434073
119 Y>C No ClinGen
gnomAD
rs745802914
CA2930714
123 P>A No ClinGen
ExAC
gnomAD
rs1406767477
CA356985889
123 P>L No ClinGen
gnomAD
CA356985897
rs1334567209
124 P>H No ClinGen
TOPMed
gnomAD
rs1334567209
CA356985900
124 P>L No ClinGen
TOPMed
gnomAD
CA97615701
rs913575905
124 P>S No ClinGen
gnomAD
CA356985913
rs1378531955
125 K>N No ClinGen
gnomAD
CA2930715
rs769916779
127 E>* No ClinGen
ExAC
gnomAD
CA356985949
rs1314694332
128 L>F No ClinGen
gnomAD
CA2930716
rs199953702
128 L>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs748286211
CA2930717
130 F>L No ClinGen
ExAC
TOPMed
gnomAD
CA356986745
rs1314038157
133 D>V No ClinGen
TOPMed
rs1263342213
CA356986768
135 N>D No ClinGen
TOPMed
gnomAD
rs1263342213
CA356986766
135 N>H No ClinGen
TOPMed
gnomAD
rs188741488
CA2930731
135 N>S No ClinGen
1000Genomes
ExAC
gnomAD
CA2930733
rs180705924
136 N>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 137 D>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs764478473
CA97616877
138 P>A No ClinGen
TOPMed
CA356986817
rs764478473
138 P>T No ClinGen
TOPMed
rs1480023389
CA356986831
139 Q>K No ClinGen
gnomAD
CA356986866
rs1196934647
140 W>C No ClinGen
gnomAD
rs138933625
CA2930734
141 S>C No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA2930737
rs772284340
142 E>D No ClinGen
ExAC
gnomAD
CA356986957
rs1410413606
145 L>P No ClinGen
gnomAD
CA356986973
rs1474104182
146 I>M No ClinGen
TOPMed
rs985483193
CA97616912
146 I>T No ClinGen
Ensembl
rs1169170580
CA356986981
147 A>D No ClinGen
gnomAD
rs1379131129
CA356986975
147 A>T No ClinGen
gnomAD
CA2930738
rs184494736
148 A>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA97616926
rs765022947
149 K>Q No ClinGen
Ensembl
CA2930739
rs771128512
153 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA97616943
rs913894439
154 G>A No ClinGen
TOPMed
rs373654453
CA97616957
156 L>F No ClinGen
ESP
gnomAD
TCGA novel 156 L>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA356987150
rs373654453
156 L>V No ClinGen
ESP
gnomAD
CA2930741
rs777026500
157 I>V No ClinGen
ExAC
gnomAD
CA2930742
rs759946495
158 G>D No ClinGen
ExAC
gnomAD
CA356987258
rs1272892168
163 D>G No ClinGen
gnomAD
CA2930744
rs770241161
164 I>S No ClinGen
ExAC
gnomAD
CA356987290
rs1215185066
165 M>I Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs1224805484
CA356987355
167 H>L No ClinGen
gnomAD
CA356987406
rs1560661288
169 T>R No ClinGen
Ensembl
rs762387719
CA356987498
173 F>C No ClinGen
ExAC
TOPMed
gnomAD
CA356987509
rs1220003851
173 F>L No ClinGen
gnomAD
rs762387719
CA2930746
173 F>S No ClinGen
ExAC
TOPMed
gnomAD
rs763578528
CA2930747
174 E>G No ClinGen
ExAC
TOPMed
gnomAD
CA356987602
rs1475600475
177 E>A No ClinGen
gnomAD
rs1185919611
CA356987611
177 E>D No ClinGen
gnomAD
rs1313881393
CA356987733
182 P>L No ClinGen
TOPMed
rs1560661325
CA356987777
184 N>S No ClinGen
Ensembl
CA2930749
rs751073813
187 L>M No ClinGen
ExAC
TOPMed
gnomAD
rs751073813
CA356987834
187 L>V No ClinGen
ExAC
TOPMed
gnomAD
rs767134289
CA2930750
188 V>D No ClinGen
ExAC
gnomAD
CA356987849
rs1364600243
188 V>I No ClinGen
gnomAD
rs750175213
CA2930751
190 M>T No ClinGen
ExAC
TOPMed
gnomAD
CA356988210
rs1266456936
200 T>A No ClinGen
TOPMed
VAR_051884
rs11549976
CA2930763
201 K>N No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA2930764
rs775884727
202 E>* No ClinGen
ExAC
TOPMed
gnomAD
CA97617076
rs775884727
202 E>K No ClinGen
ExAC
TOPMed
gnomAD
CA97617085
rs1008543492
203 I>T No ClinGen
TOPMed
CA356988314
rs1387117115
205 L>F No ClinGen
gnomAD
rs763421838
CA2930765
206 A>G No ClinGen
ExAC
TOPMed
gnomAD
CA356988330
rs1455013158
206 A>T No ClinGen
gnomAD
rs906235902
CA97617104
209 I>T No ClinGen
TOPMed
rs1242695903
CA356988448
210 D>E No ClinGen
TOPMed
gnomAD
rs1018806692
CA97617107
210 D>G No ClinGen
TOPMed
CA356988438
rs1382188652
210 D>N No ClinGen
gnomAD
CA356988456
rs1393250559
211 N>S No ClinGen
TOPMed
CA356988523
rs1281497080
213 S>C No ClinGen
gnomAD
rs1351601877
CA356988553
214 W>* No ClinGen
gnomAD
rs1293713571
CA356988576
215 R>K No ClinGen
TOPMed
rs1352487398
CA356988628
217 W>* No ClinGen
TOPMed
CA2930767
rs773900006
217 W>* No ClinGen
ExAC
gnomAD
CA356988622
rs1325385893
217 W>R No ClinGen
gnomAD
TCGA novel 218 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1459640407
CA356988783
222 R>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA356988781
rs1459640407
222 R>G No ClinGen
gnomAD
CA2930769
rs761243513
222 R>P No ClinGen
ExAC
TOPMed
gnomAD
CA2930768
rs761243513
222 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA2930771
rs760497195
225 Q>E No ClinGen
ExAC
gnomAD
CA356988856
rs1578154110
226 K>E No ClinGen
Ensembl
CA2930772
rs766254021
227 D>H No ClinGen
ExAC
gnomAD
CA356988874
rs766254021
227 D>N No ClinGen
ExAC
gnomAD
rs6825812
CA97617127
228 K>N No ClinGen
ExAC
gnomAD
CA97618274
rs984336101
230 S>C No ClinGen
TOPMed
TCGA novel 232 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs908385151
CA97618284
232 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA356990044
CA97618291
rs940745017
233 D>E No ClinGen
TOPMed
gnomAD
CA97618298
rs372939831
234 L>F No ClinGen
ESP
CA356990112
rs1270577432
236 E>A No ClinGen
gnomAD
TCGA novel 236 E>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1481626793
CA356990148
237 V>A No ClinGen
TOPMed
gnomAD
rs1036438243
CA97618304
238 T>P No ClinGen
TOPMed
rs865838824
CA356990191
239 P>S No ClinGen
gnomAD
CA97618305
rs865838824
239 P>T No ClinGen
gnomAD
TCGA novel 240 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1052633287
CA97618306
241 G>R No ClinGen
TOPMed
CA356990369
rs1376390098
245 V>A No ClinGen
TOPMed
CA356990347
rs1170119557
245 V>L No ClinGen
gnomAD
TCGA novel 246 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1578155879
CA356990446
248 N>H No ClinGen
Ensembl
rs756370715
CA2930782
248 N>T No ClinGen
ExAC
gnomAD
rs1050687283
CA97618335
250 E>Q No ClinGen
TOPMed
CA356990651
rs1578155907
251 W>* No ClinGen
Ensembl
CA356990682
rs866870232
252 V>F No ClinGen
gnomAD
rs866870232
CA97618341
252 V>I No ClinGen
gnomAD
rs866870232
CA356990672
252 V>L No ClinGen
gnomAD
CA356990703
rs1364438423
253 A>P No ClinGen
TOPMed
gnomAD
rs1270671058
CA356990742
254 E>G No ClinGen
gnomAD
rs1229572391
CA356990732
254 E>K No ClinGen
gnomAD
rs1456517711
CA356990827
256 V>L No ClinGen
TOPMed
rs1263058178
CA356989256
258 L>F No ClinGen
gnomAD
CA356989267
rs1464799645
259 L>F No ClinGen
gnomAD
rs771504681
CA2930794
259 L>P No ClinGen
ExAC
gnomAD
CA356989372
rs1221415176
263 E>D No ClinGen
TOPMed
CA2930795
rs772896399
266 C>R No ClinGen
ExAC
gnomAD
rs1445287745
CA356989421
266 C>Y No ClinGen
gnomAD
rs766199132
CA2930797
267 R>S No ClinGen
ExAC
gnomAD
CA97569349
rs993469644
268 V>L No ClinGen
TOPMed
CA356989493
rs1455165838
269 V>A No ClinGen
gnomAD
rs201075940
CA2930798
270 V>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs201075940
CA97569350
270 V>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2930800
rs765151186
273 G>S No ClinGen
ExAC
gnomAD
CA2930802
rs758414050
274 S>C No ClinGen
ExAC
gnomAD
rs367790847
CA2930805
279 G>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2930806
rs780614478
281 C>* No ClinGen
ExAC
TOPMed
gnomAD
CA2930807
rs756317430
281 C>R No ClinGen
ExAC
TOPMed
gnomAD
CA356989802
rs1207443802
282 E>G No ClinGen
gnomAD
rs1430625186
CA356989826
283 K>E No ClinGen
TOPMed
rs1202212340
CA356989874
284 I>M No ClinGen
TOPMed
rs376971719
CA2930810
287 A>D No ClinGen
1000Genomes
ExAC
gnomAD
rs780270261
CA2930809
287 A>P No ClinGen
ExAC
TOPMed
gnomAD
CA97569351
rs780270261
287 A>S No ClinGen
ExAC
TOPMed
gnomAD
CA356989967
rs780270261
287 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs1176319891
CA356990014
288 C>Y No ClinGen
TOPMed
rs1259546894
CA356990123
290 N>K No ClinGen
TOPMed
CA356990110
rs1480769855
290 N>S No ClinGen
TOPMed
CA356990219
rs1421065108
292 G>S No ClinGen
gnomAD
CA2930811
rs755330401
292 G>V No ClinGen
ExAC
gnomAD
CA2930813
rs748579905
297 L>F No ClinGen
ExAC
gnomAD
rs772673782
CA2930814
298 R>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA2930815
rs772842876
298 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1011310035
CA97569352
299 V>I No ClinGen
Ensembl
rs746573083
CA2930816
300 T>A No ClinGen
ExAC
gnomAD
rs770647186
CA2930817
302 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA97569353
rs1021316291
303 H>Y No ClinGen
Ensembl
rs941080985
CA97569354
304 K>E No ClinGen
TOPMed
gnomAD
rs1226938650
CA356990583
305 G>R No ClinGen
gnomAD
rs116600135
CA2930819
306 P>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs764923107
CA2930821
310 L>V No ClinGen
ExAC
gnomAD
rs1370337319
CA356990812
313 K>* No ClinGen
TOPMed
gnomAD
CA356990826
rs1254382663
314 A>T No ClinGen
gnomAD
CA2930824
rs762798410
315 E>* No ClinGen
ExAC
gnomAD
CA2930823
rs762798410
315 E>K No ClinGen
ExAC
gnomAD
rs1316792915
CA356990874
316 Y>C No ClinGen
Ensembl
CA356990867
rs1471492576
316 Y>H No ClinGen
gnomAD
rs1201246378
CA356990882
317 E>K No ClinGen
gnomAD
rs1002461393
CA97569355
318 G>R No ClinGen
Ensembl
rs774304478
CA356991144
319 D>G No ClinGen
ExAC
TOPMed
gnomAD
CA2930842
rs774304478
319 D>V No ClinGen
ExAC
TOPMed
gnomAD
CA356991157
rs1340094290
320 G>C No ClinGen
gnomAD
rs760696805
CA2930843
320 G>V No ClinGen
ExAC
gnomAD
rs1292757868
CA356991176
321 I>T No ClinGen
gnomAD
rs941030290
CA97569526
321 I>V No ClinGen
TOPMed
rs369448742
CA356991193
322 P>H No ClinGen
ESP
TOPMed
gnomAD
CA97569527
rs369448742
322 P>L No ClinGen
ESP
TOPMed
gnomAD
CA2930844
rs766423126
323 T>A No ClinGen
ExAC
TOPMed
gnomAD
rs1486125974
CA356991227
324 V>A No ClinGen
gnomAD
rs753990520
CA2930845
324 V>I No ClinGen
ExAC
gnomAD
CA97569528
rs371685923
332 S>N No ClinGen
ESP
rs1578158884
CA356991344
332 S>R No ClinGen
Ensembl
TCGA novel 333 N>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA356991360
rs1163903279
334 G>S No ClinGen
gnomAD
CA356991387
rs1405157639
336 G>E No ClinGen
gnomAD
rs1342126641
CA356991402
338 V>M No ClinGen
TOPMed
CA356991414
rs1347500604
339 M>V No ClinGen
TOPMed
gnomAD
CA356991510
rs1294011228
347 V>G No ClinGen
Ensembl
rs757883135
CA356991523
349 S>N No ClinGen
ExAC
TOPMed
gnomAD
rs757883135
CA2930852
349 S>T No ClinGen
ExAC
TOPMed
gnomAD
rs1363183479
CA356991551
350 C>Y No ClinGen
gnomAD
rs932199167
CA97569529
351 P>R No ClinGen
Ensembl
rs1039995172
CA97569530
353 L>F No ClinGen
TOPMed
gnomAD
rs1226420719
CA356991608
355 P>R No ClinGen
gnomAD
CA2930854
rs189395293
355 P>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA97569531
rs899984154
363 W>* No ClinGen
TOPMed
rs769276604
CA2930855
364 S>F No ClinGen
ExAC
TOPMed
gnomAD
CA356991729
rs1246112510
365 S>F No ClinGen
gnomAD
CA2930856
rs779762217
366 L>F No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 366 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1183609244
CA356991742
367 R>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1190902246
CA356991744
367 R>Q No ClinGen
TOPMed
CA356991749
rs1471585274
368 L>I No ClinGen
gnomAD
CA356991755
rs1178541128
368 L>P No ClinGen
gnomAD
CA356991761
rs1458080819
369 P>S No ClinGen
gnomAD
rs946153478
CA97569532
371 G>S No ClinGen
Ensembl
CA2930867
rs766164374
373 G>R No ClinGen
ExAC
gnomAD
CA2930868
rs763356434
374 C>S No ClinGen
ExAC
gnomAD
CA356993444
rs1578164051
376 T>N No ClinGen
Ensembl
rs752041122
CA2930870
377 V>I No ClinGen
ExAC
TOPMed
gnomAD
CA2930871
rs752041122
377 V>L No ClinGen
ExAC
TOPMed
gnomAD
CA2930872
rs768084727
378 L>P No ClinGen
ExAC
TOPMed
gnomAD
rs908001665
CA97574119
380 P>A No ClinGen
TOPMed
CA356993501
rs1286187536
382 G>R No ClinGen
gnomAD
rs942160873
CA97574129
385 Q>R No ClinGen
Ensembl
TCGA novel 389 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1347131133
CA356993592
390 I>M No ClinGen
gnomAD
TCGA novel 393 L>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs749838681
CA2930873
394 S>R No ClinGen
ExAC
TOPMed
gnomAD
CA2930875
rs369737448
396 H>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1454636962
CA356993679
398 V>I No ClinGen
TOPMed
CA2930877
rs754664792
399 W>C No ClinGen
ExAC
TOPMed
gnomAD
rs778675120
CA2930878
400 S>G No ClinGen
ExAC
TOPMed
gnomAD
CA356993728
rs1347343801
402 L>P No ClinGen
TOPMed
rs572364107
CA2930880
403 R>* No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA2930881
rs376026175
403 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA356993778
rs1200280816
407 L>W No ClinGen
gnomAD
rs745894323
CA2930882
408 N>D No ClinGen
ExAC
gnomAD
CA356993802
rs1169677475
409 T>I No ClinGen
gnomAD
rs1429399080
CA356993828
411 I>T No ClinGen
gnomAD
rs775478666
CA2930885
412 S>Y No ClinGen
ExAC
gnomAD
TCGA novel 414 K>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA356993867
rs1367274954
415 Q>P No ClinGen
gnomAD
rs763267836
CA2930886
417 D>V No ClinGen
ExAC
gnomAD
CA2930887
rs764472966
418 K>Q No ClinGen
ExAC
gnomAD
CA356993906
rs1185900447
418 K>R No ClinGen
TOPMed
CA2930888
rs774802084
420 I>T No ClinGen
ExAC
gnomAD
rs1297642271
CA356993950
422 E>G No ClinGen
gnomAD
CA2930890
rs144785850
422 E>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1219242469
CA356993960
423 C>G No ClinGen
gnomAD
rs200645694
CA2930891
423 C>Y No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA2930892
rs756627780
425 L>F No ClinGen
ExAC
TOPMed
gnomAD
rs765883096
CA2930893
426 L>Q No ClinGen
ExAC
gnomAD

1 associated diseases with P22234

[MIM: 619859]: Phosphoribosylaminoimidazole carboxylase deficiency (PAICSD)

An autosomal recessive inborn error of purine metabolism, clinically characterized by multiple congenital anomalies and early neonatal death. {ECO:0000269|PubMed:31600779}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • An autosomal recessive inborn error of purine metabolism, clinically characterized by multiple congenital anomalies and early neonatal death. {ECO:0000269|PubMed:31600779}. Note=The disease is caused by variants affecting the gene represented in this entry.

5 regional properties for P22234

Type Name Position InterPro Accession
domain PurE domain 266 - 420 IPR000031
conserved_site SAICAR synthetase, conserved site 93 - 107 IPR018236-1
conserved_site SAICAR synthetase, conserved site 187 - 195 IPR018236-2
domain SAICAR synthetase/ADE2, N-terminal 10 - 258 IPR028923
domain Class II PurE 266 - 421 IPR033626

Functions

Description
EC Number 4.1.1.21 Carboxy-lyases
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
extracellular exosome A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.

6 GO annotations of molecular function

Name Definition
5-amino-4-imidazole carboxylate lyase activity Catalysis of the reaction: 5-aminoimidazole + CO2 = 5-amino-4-imidazole carboxylate.
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
cadherin binding Binding to cadherin, a type I membrane protein involved in cell adhesion.
identical protein binding Binding to an identical protein or proteins.
phosphoribosylaminoimidazole carboxylase activity Catalysis of the reaction: 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate + 2 H(+) = 5-amino-1-(5-phospho-D-ribosyl)imidazole + CO(2).
phosphoribosylaminoimidazolesuccinocarboxamide synthase activity Catalysis of the reaction: 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate + L-aspartate + ATP = (2S)-2-[5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamido]succinate + ADP + 2 H(+) + phosphate.

5 GO annotations of biological process

Name Definition
'de novo' AMP biosynthetic process The chemical reactions and pathways resulting in the formation of adenosine monophosphate (AMP) from inosine 5'-monophosphate (IMP).
'de novo' IMP biosynthetic process The chemical reactions and pathways resulting in the formation of IMP, inosine monophosphate, by the stepwise assembly of a purine ring on ribose 5-phosphate.
'de novo' XMP biosynthetic process The chemical reactions and pathways resulting in the formation of XMP, xanthosine monophosphate, from simpler precursors.
GMP biosynthetic process The chemical reactions and pathways resulting in the formation of GMP, guanosine monophosphate.
purine nucleobase biosynthetic process The chemical reactions and pathways resulting in the formation of purine nucleobases, one of the two classes of nitrogen-containing ring compounds found in DNA and RNA, which include adenine and guanine.

2 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q9I7S8 Paics Bifunctional phosphoribosylaminoimidazole carboxylase/phosphoribosylaminoimidazole succinocarboxamide synthetase Drosophila melanogaster (Fruit fly) PR
Q9DCL9 Paics Bifunctional phosphoribosylaminoimidazole carboxylase/phosphoribosylaminoimidazole succinocarboxamide synthetase Mus musculus (Mouse) PR
10 20 30 40 50 60
MATAEVLNIG KKLYEGKTKE VYELLDSPGK VLLQSKDQIT AGNAARKNHL EGKAAISNKI
70 80 90 100 110 120
TSCIFQLLQE AGIKTAFTRK CGETAFIAPQ CEMIPIEWVC RRIATGSFLK RNPGVKEGYK
130 140 150 160 170 180
FYPPKVELFF KDDANNDPQW SEEQLIAAKF CFAGLLIGQT EVDIMSHATQ AIFEILEKSW
190 200 210 220 230 240
LPQNCTLVDM KIEFGVDVTT KEIVLADVID NDSWRLWPSG DRSQQKDKQS YRDLKEVTPE
250 260 270 280 290 300
GLQMVKKNFE WVAERVELLL KSESQCRVVV LMGSTSDLGH CEKIKKACGN FGIPCELRVT
310 320 330 340 350 360
SAHKGPDETL RIKAEYEGDG IPTVFVAVAG RSNGLGPVMS GNTAYPVISC PPLTPDWGVQ
370 380 390 400 410 420
DVWSSLRLPS GLGCSTVLSP EGSAQFAAQI FGLSNHLVWS KLRASILNTW ISLKQADKKI
RECNL